RVMD

Revolution Medicines, Inc.

RVMD · CIK 1628171 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$0M
20202025
Net Income−$1131M
20202025
Operating CF−$898M
20202025
Free Cash Flow−$914M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue——————
Gross Profit——————
R&D Expense$1.0B$0.6B$0.4B$0.3B$0.2B$0.1B
SG&A Expense——————
Operating Income$-1.2B$-0.7B$-0.5B$-0.3B$-0.2B$-0.1B
Net Income$-1.1B$-0.6B$-0.4B$-0.2B$-0.2B$-0.0B
EPS (Basic)$-5.95$-3.58$-3.86$-3.08——
EPS (Diluted)$-5.95$-3.58$-3.86$-3.08——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$2.4B$2.6B$2.1B$0.8B$0.7B$0.6B
Current Assets$2.1B$2.3B$1.9B$0.7B$0.6B$0.5B
Cash & Equivalents$0.4B$0.5B$0.7B$0.2B$0.1B$0.1B
Total Liabilities$0.7B$0.3B$0.2B$0.1B$0.1B$0.1B
Current Liabilities$0.3B$0.2B$0.1B$0.1B$0.1B$0.0B
Stockholders' Equity$1.6B$2.3B$1.8B$0.7B$0.6B$0.5B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.9B$-0.6B$-0.4B$-0.2B$-0.1B$-0.1B
Investing Cash Flow$0.1B$-0.6B$-0.3B$-0.0B$-0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.6B$1.0B$1.2B$0.3B$0.3B$0.4B
← Companies